Evidence map›Paper›PMID 36307614›Full record

ArticleBioprocess and biosystems engineering2022

Control of parallelized bioreactors II: probabilistic quantification of carboxylic acid reductase activity for bioprocess optimization.

Nikolas von den Eichen, Michael Osthege, Michaela Dölle, Lukas Bromig, Wolfgang Wiechert, Marco Oldiges, Dirk Weuster-Botz

Open access · hybridAbstract read
In one paragraph

Article in Bioprocess and biosystems engineering, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. A Guide to Bayesian Optimization in Bioprocess Engineering.Biotechnology and bioengineering · 2026
    Review
  2. Scale-down bioreactors-comparative analysis of configurations.Bioprocess and biosystems engineering · 2025
    Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Nikolas von den Eichen *Chair of Biochemical Engineering, Technical University of Munich, Garching, Germany. nikolas.eichen@tum.de.
Michael Osthege *Institute of Biotechnology: IBG-1, Forschungszentrum Jülich GmbH, Jülich, Germany.
Michaela DölleChair of Biochemical Engineering, Technical University of Munich, Garching, Germany.
Lukas BromigChair of Biochemical Engineering, Technical University of Munich, Garching, Germany.
Wolfgang WiechertInstitute of Biotechnology: IBG-1, Forschungszentrum Jülich GmbH, Jülich, Germany.
Marco OldigesInstitute of Biotechnology: IBG-1, Forschungszentrum Jülich GmbH, Jülich, Germany.
Dirk Weuster-BotzChair of Biochemical Engineering, Technical University of Munich, Garching, Germany.
Technical University of Munich · DERWTH Aachen University · DE

Funding

German Ministry of Education and Research (BMBF) 031B0463AGerman Ministry of Education and Research (BMBF) 031B0463B
6 · The paper itself

Abstract

Autonomously operated parallelized mL-scale bioreactors are considered the key to reduce bioprocess development cost and time. However, their application is often limited to products with very simple analytics. In this study, we investigated enhanced protein expression conditions of a carboxyl reductase from Nocardia otitidiscaviarum in E. coli. Cells were produced with exponential feeding in a L-scale bioreactor. After the desired cell density for protein expression was reached, the cells were automatically transferred to 48 mL-scale bioreactors operated by a liquid handling station where protein expression studies were conducted. During protein expression, the feed rate and the inducer concentration was varied. At the end of the protein expression phase, the enzymatic activity was estimated by performing automated whole-cell biotransformations in a deep-well-plate. The results were analyzed with hierarchical Bayesian modelling methods to account for the biomass growth during the biotransformation, biomass interference on the subsequent product assay, and to predict absolute and specific enzyme activities at optimal expression conditions. Lower feed rates seemed to be beneficial for high specific and absolute activities. At the optimal investigated expression conditions an activity of [Formula: see text] was estimated with a [Formula: see text] credible interval of [Formula: see text]. This is about 40-fold higher than the highest published data for the enzyme under investigation. With the proposed setup, 192 protein expression conditions were studied during four experimental runs with minimal manual workload, showing the reliability and potential of automated and digitalized bioreactor systems.

Indexed as

BioreactorsEscherichia coliBayes TheoremOxidoreductasesReproducibility of Resultscarboxylic acid reductaseOxidoreductasesAutomationBayesian modellingBioprocess developmentEscherichia coliProtein expressionStirred-tank bioreactorsWhole-cell catalysis

Identifiers

PMID36307614
PMCPMC9719892
OpenAlexW4307581353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.